Tony Hunter

Tony Hunter at the Salk Institute discovered that the Src oncoprotein is a tyrosine kinase — phosphorylating proteins on tyrosine residues — a landmark finding that transformed understanding of oncogenic signaling. This discovery established the tyrosine kinase family as a central class of oncoproteins and provided the molecular rationale for tyrosine kinase inhibitor drugs, the most successful class of targeted cancer therapies.